Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inozyme Pharma Inc.

    NASDAQ: INZY · Real-Time Price · USD
    3.98
    -0.01 (-0.25%)
    At close: Jun 16, 2025, 3:59 PM
    3.97
    -0.13%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Inozyme Pharma Statistics

    Share Statistics

    Inozyme Pharma has 64.56M shares outstanding. The number of shares has increased by 3.86% in one year.

    Shares Outstanding

    n/a
    		 64.56M

    Shares Change (YoY)

    n/a
    		 3.86%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 82.8%

    Shares Floating

    n/a
    		 43.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 700

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 3.68M, so 5.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.68M

    Short % of Shares Out

    n/a
    		 5.7%

    Short % of Float

    n/a
    		 6.16%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.71 and the forward PE ratio is -3.5. Inozyme Pharma's PEG ratio is -0.09.

    PE Ratio

    n/a
    		 -1.71

    Forward PE

    n/a
    		 -3.5

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 3.01

    P/FCF Ratio

    n/a
    		 -1.89

    PEG Ratio

    n/a
    		 -0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Inozyme Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.81.

    Current Ratio

    n/a
    		 3.56

    Quick Ratio

    n/a
    		 3.56

    Debt / Equity

    n/a
    		 0.81

    Debt / EBITDA

    n/a
    		 -0.45

    Debt / FCF

    n/a
    		 -0.51

    Interest Coverage

    n/a
    		 18.72

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,522,746.27

    Employee Count

    n/a
    		 67

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -13.48% in the last 52 weeks. The beta is 2.29, so Inozyme Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.29

    52-Week Price Change

    n/a
    		 -13.48%

    50-Day Moving Average

    n/a
    		 2.3

    200-Day Moving Average

    n/a
    		 2.84

    Relative Strength Index (RSI)

    n/a
    		 83.17

    Average Volume (20 Days)

    n/a
    		 2,075,298

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -104.03M

    Net Income

    n/a
    		 -102.02M

    EBITDA

    n/a
    		 -104.03M

    EBIT

    n/a
    		 -107.58M

    Earnings Per Share (EPS)

    n/a
    		 -1.62
    Full Income Statement

    Balance Sheet

    The company has 21.08M in cash and 46.87M in debt, giving a net cash position of -25.79M.

    Cash & Cash Equivalents

    n/a
    		 21.08M

    Total Debt

    n/a
    		 46.87M

    Net Cash

    n/a
    		 -25.79M

    Retained Earnings

    n/a
    		 -387.95M

    Total Assets

    n/a
    		 95.16M

    Working Capital

    n/a
    		 50.86M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -91.91M and capital expenditures -62K, giving a free cash flow of -91.97M.

    Operating Cash Flow

    n/a
    		 -91.91M

    Capital Expenditures

    n/a
    		 -62K

    Free Cash Flow

    n/a
    		 -91.97M

    FCF Per Share

    n/a
    		 -1.46
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    INZY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INZY is $13.5, which is 239.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $13.5

    Price Target Difference

    n/a
    		 239.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.57

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist